Australia’s Therapeutic Goods Administration (TGA) determined that Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be 'recognized' to establish a traveler’s vaccination status.
This recognition announced on November 1, 2021, is for travelers aged 12 and over who have been vaccinated with Covaxin and those 18 to 60 who have been immunized with BBIBP-CorV.
Australia Accepts China and India COVID-19 Vaccinated Travelers
U.S. FDA Reviews Heart Health Risks from mRNA Vaccine
Massachusetts based Moderna, Inc. provided an update on October 31, 2021, that the U.S. Food and Drug Administration (FDA) had notified the Company that it would require additional time to complete its assessment of Moderna’s recent Emergency Use Authorization (EUA) request.
The new EUA request is for the use of the Moderna COVID-19 vaccine (mRNA-1273) at the 100 µg dose level in adolescents 12 to 17 years of age.
Postacute COVID-19 Syndrome May Affect Physical, Cognitive Function
Increased levels of fatigue and dyspnea, decreased levels of physical activity reported; 63 percent showed at least mild cognitive impairment
CDC Panel Signs Off on Pfizer Vaccine for Younger Children
Children ages 5 to 11 years can now receive one-third of the adult dose, with two injections given three weeks apart
‘Delta Plus’ Variant Surfaces in Eight U.S. States
AY.4.2 ‘sub-lineage’ of delta may spread faster than the original variant, but there is no evidence that it causes more severe illness
EHR Data Support Reported Effectiveness of Ad26.COV2.S Vaccine
Retrospective study showed incidence rate ratio of 0.26 for SARS-CoV-2 infection in vaccinated persons versus unvaccinated controls
Access to COVID-19 Vaccines Found More Relevant than Which Vaccine
Most high-income countries have secured an abundant supply of COVID-19 vaccines. However, to these researchers’ knowledge, there is no assessment of the pragmatic effectiveness of the COVID-19 vaccines used in low- and moderate-income countries.
Published by the JAMA Network on October 29, 2021, researchers conducted an Original Investigation that found a pragmatic implementation of a group of COVID-19 vaccines was associated with a dramatic reduction in documented COVID-19 infection.
U.S. Land Ports of Entry and Ferry Terminals Reopen to Fully Vaccinated Visitors
The U.S. Department of Homeland Security (DHS) announced on October 30, 2021, that non-citizen travelers who are fully vaccinated for COVID-19 and have appropriate documentation will be permitted to enter the United States via land ports of entry (POE) and ferry terminals starting on November 8, 2021.
This shift eases long-standing restrictions on non-essential travel, consistent with public health guidance.
To prevent the spread of COVID-19, the U.S. government implemented temporary travel restrictions on March 20, 2020.
Pediatric Critical Care Professionals Experiencing Moral Distress
Professionals experiencing moral distress during COVID-19 pandemic due to factors that challenge professional integrity
COVID-19 Death Toll Tops 5 Million Worldwide
COVID-19 is now the third leading cause of death worldwide, behind only heart disease and stroke